Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

Imaging Studies for Cardiovascular System IV: CMRI

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

CXCR4 mRNA overexpression: an indicator of poor survival and predictor of response to immune checkpoint inhibitors in patients with metastatic colorectal cancer.

BMJ oncology·2026

Same author

Poorly Differentiated Signet-Ring Cell Gastroesophageal Carcinoma in a Child With No Detectable Genetic Predisposition: Report of a Rare and Highly Aggressive Tumor.

Pediatric blood & cancer·2026

Same author

CD8 PET imaging with [<sup>89</sup>Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.

Journal for immunotherapy of cancer·2026

Same author

Clinical and molecular characteristics of Class II and III BRAF mutations in colorectal cancer.

NPJ precision oncology·2026

Same author

Genomic and Transcriptomic Landscapes of MEN1-Wild-Type Low-Grade Metastatic Pancreatic NETs Uncover Key Oncogenic Drivers and Targetable Pathways.

bioRxiv : the preprint server for biology·2026

Same author

Evaluation of immuno-oncologic biomarkers and β-catenin expression in response of hepatocellular carcinomas to immunotherapy.

NPJ precision oncology·2026

Same journal

Overall Survival with [<sup>177</sup>Lu]Lu-PSMA-617 Versus [<sup>177</sup>Lu]Lu-PSMA I&T: A Propensity Score-Matched Real-World Analysis.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Toward a Biopsy-Free Diagnosis of Prostate Cancer: Potential of Combined <sup>18</sup>F-Flotufolastat PSMA PET and mpMRI.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

PSMA PET/CT-Targeted Biopsy in Men with Negative or Equivocal Multiparametric MRI and Exploratory Dynamic Total-Body PET: The FUPERMAN Study.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Erratum.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

Live from 2026 SNMMI Annual Meeting in Los Angeles!

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

Same journal

CAR T-Cell Therapy for Cancer: Updates and Challenges for Response Assessment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 24, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Immune Modulation Therapy and Imaging: Workshop Report.

Anthony F Shields^1,2, Paula M Jacobs², Mario Sznol³

¹Karmanos Cancer Institute, Wayne State University, Detroit, Michigan shieldsa@karmanos.org.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine

|August 19, 2017

Summary

This summary is machine-generated.

Imaging plays a crucial role in assessing cancer immunotherapy responses. New imaging techniques are being developed to overcome challenges like pseudoprogression and accurately measure treatment effectiveness.

Keywords:

biomarkers imaging cancer immunotherapy

More Related Videos

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Related Experiment Videos

Last Updated: Feb 24, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse

Published on: June 20, 2014

Area of Science:

Oncology
Radiology
Medical Imaging

Background:

Immunotherapy offers promising cancer treatment with prolonged responses.
Evaluating immunotherapy effectiveness is challenging due to variable and delayed responses.
Early imaging may incorrectly suggest tumor progression (pseudoprogression), complicating treatment decisions.

Purpose of the Study:

To review the current state and future directions of imaging in assessing cancer immunotherapy.
To highlight the need for improved imaging methods to evaluate treatment response and guide patient management.

Main Methods:

Discussion of current imaging modalities (CT, MRI, 18F-FDG PET) and their limitations.
Exploration of emerging imaging technologies, including radiomics and novel radiotracers.
Focus on imaging the tumor microenvironment and immune status.

Main Results:

Current imaging methods can be confounded by pseudoprogression.
Advanced imaging techniques (radiomics, PET, MRI) show potential for better response assessment.
Development of targeted imaging agents (small molecules, antibodies) to visualize immune activity.

Conclusions:

Improved imaging is essential for accurate assessment of immunotherapy response.
Validation of new imaging biomarkers in clinical trials is critical.
Integrating imaging data with clinical outcomes will drive the development of better assessment tools.